D Oxorn1, G Edelist, E Harrington, S Tsang. 1. Department of Anaesthesia, Sunnybrook Health Science Centre, Toronto Ontario, Canada. donald.oxorn@utoronto.ca
Abstract
PURPOSE: To determine the effect of isoflurane on left ventricular diastolic function, as assessed by Doppler echocardiography. METHODS: Ten patients with normal cardiovascular function were enrolled. Doppler measurements of mitral inflow velocities, and pulmonary venous blood flow velocities were measured preoperatively (transthoracic echocardiography), and intraoperatively (transesophageal echocardiography) at isoflurane MAC 1 and MAC 1.5. Heart rate and blood pressure were measured concomitantly. Variables were compared with repeated measures ANOVA. RESULTS: Isoflurane at both doses caused equal decreases in mitral inflow A(atrial systole) velocity (control: 43 +/- 12.3 cm.sec-1 vs MAC 1: 31 +/- 6.0 cm.sec-1 and MAC 1.5: 31.3 +/- 7.9 cm.sec-1 P < 0.01), the deceleration time of the mitral inflow E (early) velocity (control: 178 +/- 31.7 msec versus MAC 1: 127 +/- 38.3 msec and MAC 1.5: 137 +/- 28.4 msec, P < 0.01), and mean blood pressure (control: 91.1 +/- 15.4 mmHg versus MAC 1: 76.1 +/- 8.8 mmHg and MAC 1.5: 71.9 +/- 6.2 mmHg, P < 0.002). Isoflurane at both doses caused an equal increase in the E/A ratio (control: 1.5 +/- 0.57 vs MAC 1: 2.0 +/- 0.6 and MAC 1.5: 2.2 +/- 0.78, P < 0.01). No changes in mitral inflow E or pulmonary venous velocities were seen. CONCLUSION: The changes in Doppler velocities of mitral inflow and pulmonary venous flow with isoflurane are not consistent with prolonged left ventricular relaxation nor increased myocardial restriction, but are more likely the result of alterations in left ventricular loading conditions and atrial systolic function.
PURPOSE: To determine the effect of isoflurane on left ventricular diastolic function, as assessed by Doppler echocardiography. METHODS: Ten patients with normal cardiovascular function were enrolled. Doppler measurements of mitral inflow velocities, and pulmonary venous blood flow velocities were measured preoperatively (transthoracic echocardiography), and intraoperatively (transesophageal echocardiography) at isofluraneMAC 1 and MAC 1.5. Heart rate and blood pressure were measured concomitantly. Variables were compared with repeated measures ANOVA. RESULTS:Isoflurane at both doses caused equal decreases in mitral inflow A(atrial systole) velocity (control: 43 +/- 12.3 cm.sec-1 vs MAC 1: 31 +/- 6.0 cm.sec-1 and MAC 1.5: 31.3 +/- 7.9 cm.sec-1 P < 0.01), the deceleration time of the mitral inflow E (early) velocity (control: 178 +/- 31.7 msec versus MAC 1: 127 +/- 38.3 msec and MAC 1.5: 137 +/- 28.4 msec, P < 0.01), and mean blood pressure (control: 91.1 +/- 15.4 mmHg versus MAC 1: 76.1 +/- 8.8 mmHg and MAC 1.5: 71.9 +/- 6.2 mmHg, P < 0.002). Isoflurane at both doses caused an equal increase in the E/A ratio (control: 1.5 +/- 0.57 vs MAC 1: 2.0 +/- 0.6 and MAC 1.5: 2.2 +/- 0.78, P < 0.01). No changes in mitral inflow E or pulmonary venous velocities were seen. CONCLUSION: The changes in Doppler velocities of mitral inflow and pulmonary venous flow with isoflurane are not consistent with prolonged left ventricular relaxation nor increased myocardial restriction, but are more likely the result of alterations in left ventricular loading conditions and atrial systolic function.
Authors: T Ihara; R P Shannon; K Komamura; A Pasipoularides; T Patrick; Y T Shen; S F Vatner Journal: Cardiovasc Res Date: 1994-03 Impact factor: 10.787
Authors: Marlos Gonçalves Sousa; Roberta Carareto; Andrigo Barboza De-Nardi; Fábio L C Brito; Newton Nunes; Aparecido Antonio Camacho Journal: Can Vet J Date: 2007-03 Impact factor: 1.008